Five Prime Therapeutics, Inc. Assets, Fair Value Disclosure
Five Prime Therapeutics, Inc. had Assets, Fair Value Disclosure of $248.63 million as of 2020-12-31, per its 10-K filed 2021-03-22.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:AssetsFairValueDisclosure · last filed 2021-03-22
- 2020-12-31: Assets, Fair Value Disclosure $248.63M.
- 2020-09-30: Assets, Fair Value Disclosure $97.96M.
- 2020-06-30: Assets, Fair Value Disclosure $106.84M.
- 2020-03-31: Assets, Fair Value Disclosure $106.52M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2020-12-31 | $248.63M 10-K · filed 2021-03-22 |
| 2020-09-30 | $97.96M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $106.84M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $106.52M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $128.58M 10-K · filed 2021-03-22 |
| 2019-09-30 | $163.72M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $198.51M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $233.15M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $268.58M 10-K · filed 2020-02-27 |
| 2018-09-30 | $302.61M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $336.75M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $376.78M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $266.25M 10-K · filed 2019-02-26 |
| 2017-09-30 | $301.55M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $337.15M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $372.09M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $416.07M 10-K · filed 2018-02-27 |
| 2016-09-30 | $438.65M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $460.82M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $474.81M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $511.95M 10-K · filed 2017-02-24 |
| 2015-09-30 | $178.11M 10-Q · filed 2015-11-05 |
| 2014-12-31 | $143.78M 10-K · filed 2016-03-11 |